Mindfulness clinical trials at UCSF
3 in progress, 2 open to eligible people
E-Mindfulness Approaches for Living After Breast Cancer
open to eligible people ages 18-50
NRG-CC015 is a prospective, randomized phase III clinical trial to evaluate the efficacy of two distinct digital approaches for delivering a mindfulness-based intervention: a live, instructor-led version delivered over Zoom (MAPs LO), and an app-based, self-paced version (MAPs App). Participants will include younger breast cancer survivors (BCS) who were diagnosed with breast cancer at or before age 50 years, have completed their primary cancer treatment (i.e., surgery, radiation, and/or chemotherapy) at least 6 months earlier, and report elevated depressive symptoms.
San Francisco, California and other locations
Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity
open to eligible people ages 18 years and up
INSPIRE creates a trilingual mobile app and telehealth coaching program to promote non-pharmacologic strategies for pain management with Black, Chinese, and Latinx communities in the San Francisco Bay Area. Years 1-2 will develop the app and test it with a brief single arm pilot starting in Nov 2023. A full two arm randomized controlled trial (RCT) will being in early 2025 with changes in PEG scores as the primary outcome. Secondary outcomes include Helping to End Addiction Longterm (HEAL) common data elements.
San Francisco, California and other locations
Acceptability of MBSR for People With HS
Sorry, in progress, not accepting new patients
Hidradenitis suppurativa (HS) is a chronic inflammatory condition that causes painful, recurring abscesses and nodules. It is associated with psychological stress and impaired quality of life. Our study aims to pilot a mindfulness-based stress reduction program tailored to patients with HS, then use their feedback to improve the program.
San Francisco, California
Our lead scientists for Mindfulness research studies include Aileen Y Chang, MD Jason Satterfield, PhD.
Last updated: